معرفی
Dr. Bea Wisman is a researcher at the Faculty of Medical Sciences, University of Groningen, specializing in Molecular Oncology. Her work focuses on DNA methylation, ovarian and cervical cancer, and epigenetic biomarker development.
- Institution: University of Groningen / UMCG
- Department: Molecular Oncology
Her research explores epigenetic mechanisms in gynecological cancers, including ARID1A deficiency in ovarian clear cell carcinoma and methylation markers for cervical intraepithelial neoplasia detection. She contributes to the Dutch Archipelago of Ovarian Cancer Research biobank infrastructure and participates in the TARgeted Gynecologic Oncology (TARGON) network.
Recent publications examine DNA repair pathways in PARP inhibitor response, STING regulation in breast cancer immunology, and B cell infiltration in high-grade serous ovarian carcinoma. She co-supervises PhD candidates Hengyu Zhao and Vanessa Gallego Londoño.
Media highlights include €136,000 cancer research fundraising (2023) and advisory roles in HPV self-sampling initiatives (2021). She serves on the editorial board of Clinical Epigenetics since 2020.
